ACC 2018 Wrap-Up: Prof. Freek Verheugt’s Perspective
Dr. Freek Verheugt Presents Subscribe on iTunes or Google Play.
MANAGE Trial: Dabigatran in Patients With MI After Non-Cardiac Surgery
Dr. PJ Devereaux and Dr. Gibson Discuss Subscribe on iTunes or Google Play.
ODYSSEY Outcomes: Alirocumab Reduces CV Outcomes and All-Cause Mortality in ACS Patients
Dr. Schwartz and Dr. Gibson Discuss Subscribe on iTunes or Google Play.
VEST trial: Prevention of Early Sudden Death Post-MI
Dr. Olgin and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.
SWAP 4: Switching from Ticagrelor to Clopidogrel in Patients with Coronary Artery Disease
Dr. Angiolillo and Dr. Gibson Discuss Subscribe on iTunes or Google Play.
ODYSSEY Demonstrates a Mortality Benefit in ACS Patients
Results of the much anticipated ODYSSEY Outcomes trial were presented today by Professor Phillipe Gabriel Steg, who is the chief of cardiology at Bichat-Claude Bernard Hospital, at the American College…
Does Magnitude of CRP Level Reduction Correlate With Cardiovascular Mortality?
In a recent study published in The Lancet, it has been found that the magnitude of reduction in C Reactive Protein (CRP) levels due to treatment with Canakinumab, an interleukin 1β…
Thrombectomy Done Beyond 6 Hours has a Favorable Prognosis in Stroke Patients
In a recent study published in the New England Journal of Medicine, it was found that endovascular thrombectomy for ischemic stroke that is performed 6 to 16 hours after the…
Incorporating Non-Invasive Fractional Flow Reserve into Clinical Practice
Dr. Jeffrey Popma and Dr. Campbell Rogers Discuss Subscribe on iTunes or Google Play.